Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L04AB01	ENBREL	BioTech	Etanercept - 50mg	50mg	Injectable solution	52,197,598 L.L
L04AB01	ERELZI	BioTech	Etanercept - 50mg	50mg	Injectable solution	59,029,176 L.L
L04AB01	ERELZI	BioTech	Etanercept - 50mg	50mg	Injectable solution	40,824,526 L.L
L04AB01	ENBREL	BioTech	Etanercept - 25mg	25mg	Injectable solution	28,768,353 L.L
L04AB01	ERELZI	BioTech	Etanercept - 25mg	25mg	Injectable solution	25,751,867 L.L
L04AB01	ETANERREL	BioTech	Etanercept - 25mg/0.5ml	25mg/0.5ml	Injectable solution	5,085,100 L.L
L04AB01	ETANERREL	BioTech	Etanercept - 50mg/ml	50mg/ml	Injectable solution	9,756,719 L.L
L04AC19	ENSPRYNG	BioTech	Satralizumab - 120mg/ml	120mg/ml	Injectable solution	857,061,795 L.L
L04AX03	EBETREXAT	G	Methotrexate - 5mg	5mg	Tablet, scored	2,488,796 L.L
L04AX03	EBETREXAT	G	Methotrexate - 15mg/1.5ml	15mg/1.5ml	Injectable solution	2,135,366 L.L
M01AB05	EPARDEX	G	Diclofenac sodium - 50mg	50mg	Tablet, enteric coated	223,974 L.L
M01AB05	EPARDEX	G	Diclofenac sodium - 50mg	50mg	Tablet, enteric coated	3,246,979 L.L
M01AB05	EMIFENAC 50	G	Diclofenac sodium - 50mg	50mg	Tablet, dispersible	387,027 L.L
M01AH05	ETOXA	G	Etoricoxib - 60mg	60mg	Tablet, film coated	1,109,630 L.L
M01AH05	ETOXA	G	Etoricoxib - 60mg	60mg	Tablet, film coated	369,877 L.L
M01AH05	ETOXIB	G	Etoricoxib - 60mg	60mg	Tablet, film coated	1,217,521 L.L
M01AH05	ETOXA	G	Etoricoxib - 90mg	90mg	Tablet, film coated	1,293,928 L.L
M01AH05	ETOXA	G	Etoricoxib - 90mg	90mg	Tablet, film coated	431,309 L.L
M01AH05	ETOXIB	G	Etoricoxib - 90mg	90mg	Tablet, film coated	1,390,877 L.L
M01AH05	ETOXA	G	Etoricoxib - 120mg	120mg	Tablet, film coated	398,033 L.L
M01AH05	ETOXIB	G	Etoricoxib - 120mg	120mg	Tablet, film coated	425,998 L.L
M05BX06	EVENITY	BioTech	Romosozumab - 105mg/1.17ml	105mg/1.17ml	Injectable solution	56,729,091 L.L
M09AX10	EVRYSDI	B	Risdiplam - 0.75mg/ml	0.75mg/ml	Powder	865,644,067 L.L
N01BB54	EMLA	B	Prilocaine - 25mg/g, Lidocaine - 25mg/g	5%	Cream	1,763,121 L.L
N02AJ06	EFFERALGAN CODEINE	B	Paracetamol - 500mg, Codeine phosphate - 30mg		Tablet, effervescent scored	215,015 L.L
N02AJ06	EFFERALGAN CODEINE	B	Paracetamol - 500mg, Codeine phosphate - 30mg		Tablet, film coated	215,015 L.L
N02BE01	EFFERALGAN	B	Paracetamol - 500mg	500mg	Tablet, effervescent scored	129,009 L.L
N02BE01	EFFERALGAN	B	Paracetamol - 1g	1g	Tablet, film coated	129,009 L.L
N02BE01	EFFERALGAN	B	Paracetamol - 3%	3%	Solution	163,949 L.L
N02BE01	EFFERALGAN	B	Paracetamol - 1g	1g	Tablet, effervescent	129,009 L.L

...